Ilya Pharma is attending the 42nd Annual J.P. Morgan Healthcare Conference in SF 8-11 Jan

We're looking forward to attending the J.P. Morgan Healthcare Conference.

Anyone interested interested in collaborating or learning more about the company assets and technology or any of our current trials SITU-SAFE, SITU-SURGERY, SITU-HEAL or SITU-GUT, please out to our CEO Evelina Vågesjö to set up a meeting.


evelina.vagesjo@ilyapharma.se or through LinkedIn.